Kevin Serrano, PA
Physician Assistant · Naperville, ILNPI 1255962445
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 724 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 724 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$2K
- AbbVie$2K
- Vanda Pharmaceuticals Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$967
- Johnson & Johnson$955
- Otsuka America Pharmaceutical, Inc.$927
- plus $8K from 27 others
What the payments were for
- Consulting fees$1151%
- Food & beverage$14,61598%
- Education$1751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 75 | $1,512 |
| AbbVie | 77 | $1,506 |
| Vanda Pharmaceuticals Inc. | 49 | $1,253 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 50 | $967 |
| Johnson & Johnson | 47 | $955 |
| Otsuka America Pharmaceutical, Inc. | 46 | $927 |
| Neurocrine Biosciences, Inc. | 31 | $744 |
| Alkermes, Inc. | 38 | $691 |
| Supernus Pharmaceuticals, Inc. | 18 | $687 |
| Tris Pharma Inc | 42 | $686 |
| Lundbeck LLC | 39 | $643 |
| Axsome Therapeutics, Inc. | 23 | $629 |
| Almatica Pharma LLC | 31 | $615 |
| Ironshore Pharmaceuticals Inc. | 24 | $537 |
| Teva Pharmaceuticals USA, Inc. | 20 | $415 |
| Neos Therapeutics, LP | 35 | $378 |
| E.r. Squibb & Sons, L.L.C. | 12 | $360 |
| Collegium Pharmaceutical, Inc. | 14 | $285 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $209 |
| Idorsia Pharmaceuticals US Inc | 8 | $146 |
| Indivior Inc. | 5 | $138 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Jazz Pharmaceuticals Inc. | 5 | $97 |
| Noven Therapeutics, LLC | 5 | $94 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $60 |
| OWP Pharmaceuticals, Inc. | 3 | $55 |
| Neuronetics, Inc. | 3 | $44 |
| Adlon Therapeutics L.p. | 3 | $42 |
| Eisai Inc. | 2 | $32 |
| Luye Pharma (USA) Ltd. | 1 | $26 |
| Alfasigma USA, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Novo Nordisk | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$411
- CAPLYTA$227
- COBENFY$121
- Azstarys$120
- Auvelity$119
- SPRAVATO$115
- REXULTI$114
- Quillivant$107
- Dyanavel XR$107
- Quillichew ER$107
How this compares
$14,905 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 11 | $18,535 |
| Quetiapine Fumarate | 32 | $619 |
| Divalproex Sodium | 22 | $446 |
| Escitalopram Oxalate | 29 | $336 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 33 | $328 |
| Duloxetine Hcl | 14 | $318 |
| Fluoxetine Hcl | 17 | $292 |
| Topiramate | 11 | $256 |
| Bupropion XlBupropion Hcl | 17 | $254 |
| Risperidone | 18 | $245 |
| Lorazepam | 38 | $238 |
| Clonazepam | 53 | $216 |
| Temazepam | 14 | $171 |
| Aripiprazole | 13 | $157 |
| Lamotrigine | 12 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $955 | $18,53511 claims |
| Almatica Pharma LLCSertraline Hcl | $615 | $2312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Naperville
- Meraj BaigNaperville$12K
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.